Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Clostridioides difficile (formerly Clostridium difficile) bacterial cell surface receptors, primarily represented by the Surface Layer Protein A (SlpA) and a family of associated Cell Wall Proteins (CWPs), are critical structural and functional components of the bacterial envelope. SlpA is the most abundant protein on the vegetative cell surface, where it assembles into a paracrystalline S-layer that provides structural integrity and serves as a major adhesin for binding to the host's intestinal epithelium. These surface proteins are essential for the initial stages of colonization, biofilm formation, and the regulation of toxin secretion (TcdA and TcdB), which are the primary drivers of C. difficile infection (CDI) pathogenesis. Additionally, SlpA acts as a primary receptor for many C. difficile-specific bacteriophages and R-type bacteriocins, making it a high-priority target for narrow-spectrum therapeutic interventions. Targeting these receptors with monoclonal antibodies, vaccines, or phage-based therapies aims to prevent bacterial adhesion and colonization, thereby reducing the incidence and recurrence of CDI while preserving the protective gut microbiota.
Inhibition of bacterial adhesion to host cells, disruption of S-layer assembly, and phage-mediated bacterial lysis to prevent colonization and virulence.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Clostridioides difficile surface layer protein A (SlpA) (SlpA).